News Biotech Showcase™ | Investor conference | Co-produced by Demy-Colton and EBD Group We are now only a few weeks out from Biotech Showcase and excited to launch…Super UserJanuary 4, 2021
News 7 Cell Therapy Companies in Maryland Helping to Revolutionize Drug Discovery: The Latest News | American Gene Technologies Maryland is home to one of the largest life science clusters in the United States…Super UserJanuary 4, 2021
News Emmes Acquires Neox s.r.o., a Clinical Research Organization Headquartered in the Czech Republic ROCKVILLE, Md., Dec. 30, 2020 /PRNewswire/ -- Emmes, a global, full-service Clinical Research Organization (CRO) dedicated…Super UserJanuary 4, 2021
News U.K. Authorizes Covid-19 Vaccine From Oxford and AstraZeneca – The New York Times LONDON — Britain on Wednesday became the first country to give emergency authorization to the…Super UserJanuary 4, 2021
BHI Weekly News Archives 436th Edition, December 29, 2020 BioHealth Innovation If you are having trouble viewing this email, please click here December 29,…Super UserDecember 29, 2020
BHI Weekly News Archives 435th Edition, December 22, 2020 BioHealth Innovation If you are having trouble viewing this email, please click here December 22,…Super UserDecember 29, 2020
BHI Weekly News Archives 434th Edition, December 15, 2020 BioHealth Innovation If you are having trouble viewing this email, please click here December 15,…Super UserDecember 29, 2020
News Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in the United States and Mexico | Novavax Inc. – IR Site GAITHERSBURG, Md., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology…Super UserDecember 28, 2020
News REGENXBIO Announces Agreement to Monetize Portion of Zolgensma® Royalties for $200 Million | BioSpace ROCKVILLE, Md., Dec. 22, 2020 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company…Super UserDecember 28, 2020
News REGENXBIO Announces Agreement to Monetize Portion of Zolgensma® Royalties for $200 Million | BioSpace ROCKVILLE, Md., Dec. 22, 2020 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company…Super UserDecember 28, 2020